RETRACTED: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- 1 December 2009
- journal article
- retracted article
- Published by Elsevier in Cancer Cell
- Vol. 16 (6) , 498-509
- https://doi.org/10.1016/j.ccr.2009.10.014
Abstract
No abstract availableKeywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro
This publication has 47 references indexed in Scilit:
- Role of Cyclin D1 as a Mediator of c-Met– and β-Catenin–Induced HepatocarcinogenesisCancer Research, 2008
- Akt Regulates Drug-Induced Cell Death through Bcl-w DownregulationPLOS ONE, 2008
- MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase RegulatorsMolecular and Cellular Biology, 2008
- PAK Is Regulated by PI3K, PIX, CDC42, and PP2Cα and Mediates Focal Adhesion Turnover in the Hyperosmotic Stress-induced p38 PathwayJournal of Biological Chemistry, 2008
- Akt inactivates ERK causing decreased response to chemotherapeutic drugs in advanced CaP cellsCell Cycle, 2008
- Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferationThe EMBO Journal, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Combined Signaling through ERK, PI3K/AKT, and RAC1/p38 Is Required for Met-triggered Cortical Neuron MigrationJournal of Biological Chemistry, 2006
- Promoting apoptosis as a strategy for cancer drug discoveryNature Reviews Cancer, 2005
- The functions of animal microRNAsNature, 2004